Women Have a Powerful New Tool to See Their Risk of Breast Cancer, and It Works With an Existing Mammogram Image

FDA Approves Lilly’s New Oral Combo Pill for Common Breast Cancer Mutation. The Eli Lilly corporate headquarters in Indianapolis, IN, on August 15, 2024. AJ Mast/Bloomberg via Getty Images The FDA approved a new oral combo drug for a common breast cancer mutation on September 18. The treatment includes Inluriyo (imlunestrant) taken with Verzenio (abemaciclib) for adults with ER-positive, HER2-negative advanced or metastatic breast cancer with ESR1 mutation that has spread after hormone therapy. Results from a trial show that among 159 participants with ESR1 mutations, those taking the combination went a median of 11.1 months before their cancer spread,.

Widdecombe suspect charged with planning terror act against Farage. Counter terror police say the further charge comes after a "hugely intensive and complex investigation".

43 Percent of Job Seekers Are Hiding Their Best Qualifications to Get Hired. A Monster survey finds job seekers are downplaying experience, accomplishments, and titles because they fear being rejected as overqualified.

Zara Just Launched Its John Galliano Collection. It’s Being Called ‘Cheap Fabric With Hot Glue’. The launch comes just a month after the controversial designer withdrew from a Met exhibition in his honor.

Elite Navy special warfare boat crews may be returning to duty with undiagnosed brain injuries, Pentagon watchdog warns. The report said that sending service members back into high-risk environments with an undiagnosed brain injury could negatively affect operations.

Bald Birds Brewing Tried to Scale. Now a Former Partner Wants $18.5 Million. The Pennsylvania brewery sought expansion through the B3 Beverage platform. Now it faces claims involving unpaid loans, wages, leases, and debts.